The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Back to Lifestyle
Lifestyle
October 1, 2026 at 10:30 AM
STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
STAT News
Excerpt from STAT News.